Combination of Gemcitabine and Imatinib Mesylate in Pemetrexed-pretreated Patients With Pleural Mesothelioma

NCT02303899 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Mesothelioma, Malignant

Interventions

DRUG: Gemcitabine
DRUG: Imatinib mesylate

Sponsor

Istituto Clinico Humanitas